查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1302061

腦脊液管理市場：副產品（腦脊液引流、腦脊液分流）、最終用戶（成人最終用戶、老年最終用戶、兒科最終用戶） - COVID-19、俄羅斯-烏克蘭衝突和高通脹影響的累積 - 2023-2030 年全球預測

Cerebral Spinal Fluid Management Market by Product (CSF Drainage, CSF Shunts), End-User (Adult End Users, Geriatric End Users, Pediatric End Users) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球腦脊液管理市場將達到16.3286億美元，複合年增長率為6.21%，大幅增長，2030年將達到24.9391億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球腦脊液管理市場至關重要。 通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的決策。 這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場份額分析

市場份額分析可以深入了解供應商在特定市場區域的當前狀態。 比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場份額時的表現以及面臨的情況。 該分析還揭示了特定行業的競爭程度、積累和分散的優勢以及研究基準年的併購特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要公司所服務的市場的全面信息。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細信息，並分析其在成熟市場領域的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新開發和投資的詳細信息。

4. 市場趨勢：全面了解 COVID-19、俄羅斯-烏克蘭衝突和高通脹的累積影響。

5.競爭評估與信息：對各大公司的市場份額、戰略、產品、認證、監管狀況、專利狀況、製造能力進行綜合評估。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

此報告回答了以下問題：

1.腦脊液管理的全球市場規模和預測是多少？

2. 在預測期內，COVID-19 對全球腦脊液管理市場的抑制因素和影響有哪些？

3.在預測期內，全球腦脊液管理市場需要投資哪些產品/細分市場/應用/領域？

4.全球腦脊液管理市場的競爭策略是什麼？

5.全球腦脊液管理市場的技術趨勢和監管框架是什麼？

6.全球腦脊液管理市場主要廠商的市場份額是多少？

7. 哪些形式和戰略舉措被認為適合進入全球腦脊液管理市場？

目錄

第一章前言

第二章研究方法

第 3 章執行摘要

第四章市場概述

第 5 章市場洞察

  • 市場動態
    • 促進因素
      • 嬰兒和老年人腦積水和神經系統疾病的患病率增加
      • 後續分流手術數量增加
      • 政府努力改善醫療基礎設施
    • 抑制因素
      • 手術費用高
    • 機會
      • CSF 管理的技術進步和發展
      • 對正在進行的與腦屏障和腦液相關的研究項目進行快速投資
    • 作業
      • 缺乏熟練的專業人員和產品召回
  • 市場趨勢
  • 新冠肺炎 (COVID-19) 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通脹的累積影響
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 監管框架
  • 客戶定制

第 6 章腦脊液管理市場：按產品

  • 腦脊液引流
  • 腦脊液分流術

第 7 章腦脊液管理市場：按最終用戶劃分

  • 成人最終用戶
  • 老年最終用戶
  • 兒科最終用戶

第八章北美和南美腦脊液管理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第九章亞太地區腦脊液管理市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的腦脊液管理市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 意大利
  • 荷蘭
  • 尼日利亞
  • 挪威
  • 波蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合酋長國
  • 英國

第11章競爭態勢

  • FPNV定位矩陣
  • 市場份額分析：按主要公司劃分
  • 競爭情景分析：主要公司

第12章上市公司名單

第13章附錄

  • 討論指南
  • 關於許可證和價格
Product Code: MRR-AD36CD89816B

The Global Cerebral Spinal Fluid Management Market is forecasted to grow significantly, with a projected USD 1,632.86 million in 2023 at a CAGR of 6.21% and expected to reach a staggering USD 2,493.91 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cerebral Spinal Fluid Management Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cerebral Spinal Fluid Management Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across CSF Drainage and CSF Shunts. The CSF Drainage is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Adult End Users, Geriatric End Users, and Pediatric End Users. The Geriatric End Users is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cerebral Spinal Fluid Management Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cerebral Spinal Fluid Management Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cerebral Spinal Fluid Management Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cerebral Spinal Fluid Management Market?

4. What is the competitive strategic window for opportunities in the Global Cerebral Spinal Fluid Management Market?

5. What are the technology trends and regulatory frameworks in the Global Cerebral Spinal Fluid Management Market?

6. What is the market share of the leading vendors in the Global Cerebral Spinal Fluid Management Market?

7. What modes and strategic moves are considered suitable for entering the Global Cerebral Spinal Fluid Management Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cerebral Spinal Fluid Management Market, by Product, 2022 vs 2030
  • 4.3. Cerebral Spinal Fluid Management Market, by End-User, 2022 vs 2030
  • 4.4. Cerebral Spinal Fluid Management Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise prevalence of hydrocephalus and neurological disorders among babies and the elderly population
      • 5.1.1.2. Subsequent growth in the number of shunting procedures
      • 5.1.1.3. Government initiative to improve healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of surgical procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and developments in CSF management
      • 5.1.3.2. Rapid investments in ongoing research projects related to brain barriers and brain fluids
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and product recalls
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Cerebral Spinal Fluid Management Market, by Product

  • 6.1. Introduction
  • 6.2. CSF Drainage
  • 6.3. CSF Shunts

7. Cerebral Spinal Fluid Management Market, by End-User

  • 7.1. Introduction
  • 7.2. Adult End Users
  • 7.3. Geriatric End Users
  • 7.4. Pediatric End Users

8. Americas Cerebral Spinal Fluid Management Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cerebral Spinal Fluid Management Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cerebral Spinal Fluid Management Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CEREBRAL SPINAL FLUID MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 6. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. CEREBRAL SPINAL FLUID MANAGEMENT MARKET DYNAMICS
  • FIGURE 8. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. CEREBRAL SPINAL FLUID MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY CSF DRAINAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 8. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY ADULT END USERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY GERIATRIC END USERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PEDIATRIC END USERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. CEREBRAL SPINAL FLUID MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 98. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 99. CEREBRAL SPINAL FLUID MANAGEMENT MARKET LICENSE & PRICING